Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
about
Neuropeptide Y in normal eating and in genetic and dietary-induced obesityInsights into the role of neuronal glucokinaseGut-brain peptides in corticostriatal-limbic circuitry and alcohol use disordersCurrent trends in targeting the hormonal regulation of appetite and energy balance to treat obesity.Regulation of appetite to treat obesity.Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia.Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y.Moderate long-term modulation of neuropeptide Y in hypothalamic arcuate nucleus induces energy balance alterations in adult rats.Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screeningSizing up pharmacotherapy for obesityGlucokinase activity in the arcuate nucleus regulates glucose intake.Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotypeNeuropeptide Y signaling modulates the expression of ethanol-induced behavioral sensitization in mice.Gut-Brain Endocrine Axes in Weight Regulation and Obesity PharmacotherapyExpression of the glucocorticoid-induced receptor mRNA in rat brainCentral neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptorsTherapeutic potential of neuropeptide Y (NPY) receptor ligands.Antidepressant-like activity of the neuropeptide Y Y5 receptor antagonist Lu AA33810: behavioral, molecular, and immunohistochemical evidence.Central functions of neuropeptide Y in mood and anxiety disorders.Fat mass and obesity-associated (FTO) protein interacts with CaMKII and modulates the activity of CREB signaling pathway.Neuropeptide systems and new treatments for nicotine addiction.Selective role of neuropeptide Y receptor subtype Y2 in the control of gonadotropin secretion in the rat.Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus.Hypothalamic interactions between neuropeptide Y, agouti-related protein, cocaine- and amphetamine-regulated transcript and alpha-melanocyte-stimulating hormone in vitro in male rats.Topiramate normalizes hippocampal NPY-LI in flinders sensitive line 'depressed' rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-inducing effects.Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.Neuroendocrine regulation of eating behavior.Association of genetic polymorphisms of glutamate decarboxylase 2 and the dopamine D2 receptor with obesity in Taiwanese subjects.NPY receptor subtype specification for behavioral adaptive strategies during limited food access.Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework
P2860
Q24669972-22BFB48E-FCEC-4B82-9D28-051BD9A067E6Q26748833-5BD12169-1E08-4599-A5A0-430F8C39E7B1Q27014840-E3064967-BCC8-4B29-9AF4-C515298DB40AQ30399390-5EE8A8AD-6FBD-47A7-B60D-009372AB71F7Q30403705-617CB107-0773-4432-80BB-54D0F85515DDQ30427268-0E1D73FD-D146-44FC-A6B7-4D1BFCC17309Q30453815-2F19D55C-F1F7-4373-AEB7-4BEDF81CEC6DQ31027469-AB9DCFBC-94CF-4CD2-91D3-3F2AEE2C176BQ33574694-D2A791EF-1C9C-4805-8B14-0728F9AF17F6Q33969368-A1BCEBEB-7913-4BB8-B0FC-68143E6D5A0FQ34452560-6F3CE2D4-72E9-477A-AA4E-2E61E9C071EBQ34988146-4E130BAE-15EA-4357-8A15-DD16B2447ED1Q35402218-80A5EEAD-9BA8-4C73-81BE-96B644ACBEAEQ35667150-37CC3A3C-97DF-409B-B613-8C9B12F95B74Q35669967-D9FEA01D-65B5-4291-85E1-47198920F8ADQ35892722-B23BB59D-EFE2-47AA-84FF-04046D3735F3Q36088880-7420B2D6-EA4C-46AB-B12E-99F36205E78FQ37604161-8E4C4038-82F7-4900-8477-20D391E858D0Q37945311-003A042A-4E35-4CC5-8FE5-FBCBBB045771Q39027921-734573DE-11DC-4BBA-809D-F863EED821E3Q39059946-819F39E1-A2DC-4D60-94A2-B96F3EA24438Q42518296-58E5C7D3-365E-491F-ABAE-EB2DCEF17403Q43777373-FD08EF72-2D4F-4488-B8E3-E834C117EB6AQ44126274-29D0E04B-89AE-459E-982E-AE0876C37BB7Q44407116-F6FF7CE7-CFF9-4325-9215-BB413C20F954Q47834686-F3E92F07-3B0F-431F-BDEB-5120DBB09BDDQ48415057-E3E11463-F509-4A9A-95E6-152E885C9E80Q48640183-F73CD8C3-3671-49D7-B415-A6B146708381Q48894760-A6140021-C927-4961-B257-6C1252A9CBF7Q58788199-7C7FB42C-3EFC-4839-89DA-D14FCEA5414C
P2860
Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Regulation of neuropeptide Y r ...... onists in hypothalamic slices.
@ast
Regulation of neuropeptide Y r ...... onists in hypothalamic slices.
@en
type
label
Regulation of neuropeptide Y r ...... onists in hypothalamic slices.
@ast
Regulation of neuropeptide Y r ...... onists in hypothalamic slices.
@en
prefLabel
Regulation of neuropeptide Y r ...... onists in hypothalamic slices.
@ast
Regulation of neuropeptide Y r ...... onists in hypothalamic slices.
@en
P2093
P2860
P1476
Regulation of neuropeptide Y r ...... onists in hypothalamic slices.
@en
P2093
P2860
P304
P356
10.1046/J.1471-4159.1999.0730641.X
P407
P577
1999-08-01T00:00:00Z